entertainment -WSS

entertainment

author：hotspot 2025-10-01 11:44:52 - browse：5

Illustration of the U.S. made of blue and white lines. -- health tech coverage from STAT — Adobe

A group of academic hospitals and technology companies will form a new nonprofit venture to oversee a nationwide network of laboratories to test artificial intelligence tools designed for use in health care.

The nonprofit will establish the laboratories at Mayo Clinic, Duke, Stanford, and other major universities and institutions around the country. Its goal is to create a system to certify and register AI models, and publish details about their performance before they are widely adopted. The labs are expected to begin operating within the next few months.

The nonprofit’s launch, unfolding amid rapid innovation and investment in AI, is an attempt at industry self-policing as increasingly powerful — and opaque — algorithmic models begin making their way into medical settings. It is being formed by a group known as the Coalition for Health AI, whose leadership includes technology experts at the academic hospitals that would host the testing labs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Questions and answers about ramping up H5N1 bird flu vaccine

WSS

Criminal prosecution for violating HIPAA: an emerging threat

Investigation reveals sickle cell patients pressured into sterilizations

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Liver decline slowed by off

Data integrity in scientific journals requires "effort" by publishers, institutions

When prostate cancer spreads, where it goes matters

explore

entertainment

hotspot

At least 13 dead in Texas as scorching temps continue

For longer

New air purifier tech could be key to improving indoor air quality

Venture capitalist Bob Kocher on the state of digital health

After affirmative action ruling, medical educators look to 'holistic review'

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Heart attack and stroke risk calculators need revising

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Duchenne breakthrough therapy leaves behind pioneering families

Readers respond to H5N1 and livestock movements, and more

leisure time

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Cytokinetics CEO stresses company can launch heart drug on its own

Fentanyl is making it harder to start addiction treatment

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

knowledge

leisure time

entertainment

focus